281 related articles for article (PubMed ID: 11687960)
1. HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer.
Shamay M; Agami R; Shaul Y
Oncogene; 2001 Oct; 20(47):6811-9. PubMed ID: 11687960
[TBL] [Abstract][Full Text] [Related]
2. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
Tu H; Gao HF; Ma GH; Liu Y
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883
[TBL] [Abstract][Full Text] [Related]
3. Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis.
Caselmann WH
J Hepatol; 1995; 22(1 Suppl):34-7. PubMed ID: 7602073
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
[TBL] [Abstract][Full Text] [Related]
5. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
6. Characterization of integration patterns and flanking cellular sequences of hepatitis B virus in childhood hepatocellular carcinomas.
Tsuei DJ; Chang MH; Chen PJ; Hsu TY; Ni YH
J Med Virol; 2002 Dec; 68(4):513-21. PubMed ID: 12376959
[TBL] [Abstract][Full Text] [Related]
7. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma.
Yeh CT; Shen CH; Tai DI; Chu CM; Liaw YF
Oncogene; 2000 Nov; 19(46):5213-20. PubMed ID: 11077437
[TBL] [Abstract][Full Text] [Related]
9. Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis.
Wang Y; Lau SH; Sham JS; Wu MC; Wang T; Guan XY
Oncogene; 2004 Jan; 23(1):142-8. PubMed ID: 14712219
[TBL] [Abstract][Full Text] [Related]
10. Integrated hepatitis B virus X and 3' truncated preS/S sequences derived from human hepatomas encode functionally active transactivators.
Schlüter V; Meyer M; Hofschneider PH; Koshy R; Caselmann WH
Oncogene; 1994 Nov; 9(11):3335-44. PubMed ID: 7936659
[TBL] [Abstract][Full Text] [Related]
11. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator.
Kekulé AS; Lauer U; Meyer M; Caselmann WH; Hofschneider PH; Koshy R
Nature; 1990 Feb; 343(6257):457-61. PubMed ID: 2153938
[TBL] [Abstract][Full Text] [Related]
12. Hepatoma-derived integrated HBV DNA causes multi-stage transformation in vitro.
Luber B; Arnold N; Stürzl M; Höhne M; Schirmacher P; Lauer U; Wienberg J; Hofschneider PH; Kekulé AS
Oncogene; 1996 Apr; 12(8):1597-608. PubMed ID: 8622879
[TBL] [Abstract][Full Text] [Related]
13. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
Kim DG
Methods Mol Biol; 2006; 317():141-55. PubMed ID: 16264227
[TBL] [Abstract][Full Text] [Related]
14. Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA.
Tamori A; Yamanishi Y; Kawashima S; Kanehisa M; Enomoto M; Tanaka H; Kubo S; Shiomi S; Nishiguchi S
Clin Cancer Res; 2005 Aug; 11(16):5821-6. PubMed ID: 16115921
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a specific region in the hepatitis B virus enhancer I for the efficient expression of X gene in the hepatic cell.
Fukai K; Takada S; Yokosuka O; Saisho H; Omata M; Koike K
Virology; 1997 Sep; 236(2):279-87. PubMed ID: 9325235
[TBL] [Abstract][Full Text] [Related]
16. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels.
Yuen MF; Tanaka Y; Shinkai N; Poon RT; But DY; Fong DY; Fung J; Wong DK; Yuen JC; Mizokami M; Lai CL
Gut; 2008 Jan; 57(1):98-102. PubMed ID: 17483190
[TBL] [Abstract][Full Text] [Related]
17. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
18. Characterization of two hepatitis B virus populations in a single Korean hepatocellular carcinoma patient with an HBeAg-negative serostatus: a novel X-Gene-deleted strain with inverted duplication sequences of upstream enhancer site II.
Kim H; Jee Y; Mun HS; Park JH; Yoon JH; Kim YJ; Lee HS; Hyun JW; Hwang ES; Cha CY; Kook YH; Kim BJ
Intervirology; 2007; 50(4):273-80. PubMed ID: 17570929
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma].
Wang XH; Wang PL
Ai Zheng; 2003 Jul; 22(7):715-8. PubMed ID: 12866962
[TBL] [Abstract][Full Text] [Related]
20. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.
Chou YC; Yu MW; Wu CF; Yang SY; Lin CL; Liu CJ; Shih WL; Chen PJ; Liaw YF; Chen CJ
Gut; 2008 Jan; 57(1):91-7. PubMed ID: 17502344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
